Header Logo

Connection

JOSEPH JANKOVIC to Quality of Life

Back to Details
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Quality of Life.
JOSEPH JANKOVIC
Connection Strength
1.250
Quality of Life
  1. Young-onset Parkinson's disease: Its unique features and their impact on quality of life. Parkinsonism Relat Disord. 2019 08; 65:39-48.
    View in: PubMed
    Score: 0.303
  2. Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010 Mar; 81(3):315-9.
    View in: PubMed
    Score: 0.154
  3. The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry. 2005 Sep; 76(9):1188-93.
    View in: PubMed
    Score: 0.117
  4. An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms. Expert Rev Neurother. 2024 Oct; 24(10):1025-1033.
    View in: PubMed
    Score: 0.108
  5. Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore). 2023 Jul 01; 102(S1):e32403.
    View in: PubMed
    Score: 0.100
  6. Deutetrabenazine for the treatment of Huntington's chorea. Expert Rev Neurother. 2018 08; 18(8):625-631.
    View in: PubMed
    Score: 0.071
  7. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia. Drugs. 2016 May; 76(7):779-87.
    View in: PubMed
    Score: 0.061
  8. Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia. Drugs. 2016 May; 76(7):759-77.
    View in: PubMed
    Score: 0.061
  9. New and emerging medical therapies in Parkinson's disease. Expert Opin Pharmacother. 2016; 17(7):895-909.
    View in: PubMed
    Score: 0.060
  10. Treatment of dystonia. Neurotherapeutics. 2014 Jan; 11(1):139-52.
    View in: PubMed
    Score: 0.052
  11. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial. J Neurol Sci. 2009 Oct 15; 285(1-2):195-7.
    View in: PubMed
    Score: 0.038
  12. Evidence-based review of patient-reported outcomes with botulinum toxin type A. Clin Neuropharmacol. 2004 Sep-Oct; 27(5):234-44.
    View in: PubMed
    Score: 0.027
  13. Longitudinal predictors of health-related quality of life in isolated dystonia. J Neurol. 2024 Feb; 271(2):852-863.
    View in: PubMed
    Score: 0.026
  14. Dystonia. Nat Rev Dis Primers. 2018 09 20; 4(1):25.
    View in: PubMed
    Score: 0.018
  15. Post-traumatic movement disorders: effect of the legal system on outcome. J Forensic Sci. 1998 Mar; 43(2):334-9.
    View in: PubMed
    Score: 0.017
  16. Thalamic DBS with a constant-current device in essential tremor: A?controlled clinical trial. Parkinsonism Relat Disord. 2017 Jul; 40:18-26.
    View in: PubMed
    Score: 0.016
  17. Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). J Neurol. 2014 Jul; 261(7):1309-19.
    View in: PubMed
    Score: 0.013
  18. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol. 2004 Jul; 61(7):1044-53.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.